Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

ACG Metals, Allergy Therapeutics, Frontier IP Group, Hercules, Helium One, Genflow Biosciences - Small Cap Snapshot

ACG Metals, Allergy Therapeutics, Frontier IP Group, Hercules, Helium One, Genflow Biosciences - Small Cap Snapshot

ACG Metals Ltd (LSE:ACG, FRA:Y9C, OTC:ACGAF) beat 2025 production guidance as costs fell sharply at its Gediktepe mine in Turkey. It’s on track to become a copper producer this year, with expansion works on time and on budget. Read more

Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) saw first-half revenues rise as Germany recovered and a new product launched. Its first new allergy injection in Germany for 20 years is now selling, with management confident on full-year growth. Read more

Frontier IP Group PLC (LSE:FIPP, FRA:8WT) said a pig vaccine from portfolio company The Vaccine Group beat a leading rival in trials. The results boost hopes the technology can work across animals and diseases, with commercial talks now underway. Read more

Hercules PLC (LSE:HERC) has joined Balfour Beatty’s preferred supplier list for UK power transmission work. It also pushed back final results to March, citing extra audit work after a busy year of acquisitions. Read more

Helium One Global Ltd (AIM:HE1, OTCQB:HLOGF, FRA:9K3) has started pump testing at its flagship Tanzania helium well. The work will assess deeper zones at the southern Rukwa Helium Project over the next few weeks, with updates expected as testing continues. Read more

Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) has appointed biotech veteran Gad Berdugo as chairman. The move supports plans to take its gene therapy research closer to the clinic and, eventually, the market. Read more

Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK